Anne Bakker
Contact details
Research on the use of patient-reported outcome measures (PROMs) to assess quality of life, with a focus on fatigue and the effects of new treatments.
Treatment for childhood cancer often leads to a reduced quality of life. Using patient-reported outcome measures (PROMs) can provide better insight into how the disease and its treatment affect quality of life.
Aims of the study
This project aims to a better understanding of the use and interpretation of PROMs, their outcomes (quality of life, fatigue) and associated factors across different phases of care, from active treatment to survivorship.
To describe PROMs used to measure HRQoL during treatment.
To provide benchmark scores for the most commonly used cancer-specific PROM for use in pediatric oncology care and research; the PedsQL Cancer Module.
To identify early predictors of the course of fatigue after treatment for childhood cancer.
To describe HRQoL in pediatric cancer patients treated with immuno- or cellular therapy.
Execution of the study
This study uses data collected through the KLIK program, which is offered as part of standard care via the KLIK PROM portal at the Princess Máxima Center. Within this program, patients and their parents complete questionnaires about quality of life.
Research team
Prof. dr. M.A. Grootenhuis (promotor), Dr. R.R.L. van Litsenburg (co-promotor), Dr. K.L.A. van Bindsbergen (co-promotor), Dr. Heleen Maurice-Stam
- Publications